Reversal of EBV immortalization precedes apoptosis in IL-6-induced human B cell terminal differentiation

Immunity

Volumn 7, Issue 5, 1997, Pages 667-677

  Altmeyer, Anne ^a   Simmons, Rosalind C ^a   Krajewski, Stanislaw ^b   Reed, John C ^b   Bornkamm, Georg W ^c   Chen Kiang, Selina ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b BURNHAM INSTITUTE   (United States)

^c Inst Klin Molekularbiologie T   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL CYCLE; CELL IMMORTALIZATION; CELL TRANSFORMATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS CELL INTERACTION;

EID: 0031462504     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80387-8     Document Type: Article

References (73)

1. Abbot, S.D., Rowe, M., Cadwallader, K., Ricksten, A., Gordon, J., Wang, F., Rymo, L., and Rickinson, A.B. (1990). Epstein-Barr virus nulear antigen 2 induces expression of the virus-encoded latent membrane protein. J. Virol. 64, 2126-2134.
2. Akashi, K., and Weissman, I.L. (1996). The c-kit maturation pathway in mouse thymic T cell development: lineages and selection. Immunity 5, 147-161.
3. Allday, M.J., Crawford, D.H., and Griffin, B.E. (1989). Epstein-Barr virus latent gene expression during the initiation of B cell immortalization. J. Gen. Virol. 70, 1755-1764.
4. Andree, H.A., Reutelingsperger, C.P., Hauptmann, R., Hemker, H.C., Hermens, W.T., and Willems, G.M. (1990). Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J. Biol. Chem. 265, 4923-4928.
5. Baer, R., Bankier, A.T., Biggin, M.D., Deininger, P.L., Farrell, P.J., Gibson, T.J., Hatfull, G., Hudson, G.S., Satchwell, S.C., Seguin, C., et al. (1984). DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310, 207-211.
6. Banchereau, J., Bazan, F., Blanchard, D., Briere, F., Galizzi, J.P., van Kooten, C., Liu, Y.J., and Saeland, R.S. (1994).The CD40 antigen and its ligand. Annu. Rev. Immunol. 12, 881-922.
7. Cayrol, C., and Flemington, E.K. (1996). The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. EMBO J. 15, 2748-2759.
8. Chen-Kiang, S. (1995). Regulation of terminal differentiation of human B-cells by IL-6. Curr. Top. in Microbiol. Immunol. 194, 189-198.
9. Cohen, J., Wang, F., Mannick, J., and Kieff, E. (1989). Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl. Acad. Sci. USA 86, 9558-9562.
10. Cory, S. (1995). Regulation of lymphocyte survival by the Bcl-2 gene family. Annu. Rev. Immunol. 13, 513-543.
11. Devergne, O., Hatzivassiliou, E., Izumi, K.M., Kaye, K.M., Kleijnen, M.F., Kieff, E., and Mosialos, G. (1996). Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-κB activation. Mol. Cell. Biol. 16, 7098-7108.
12. Fahraeus, R., Jansson, A., Ricksten, A., Sjoblom, A., and Rymo, L. (1990). Epstein-Barr-virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. Proc. Natl. Acad. Sci. USA 87, 7390-7394.
13. Faleiro, L., Kobayashi, R., Fearnhead, H., and Lazebnik, Y. (1997). Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells. EMBO J. 16, 2271-2281.
14. Fries, K.L., Miller, W.E., and Raab-Traub, N. (1996). Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J. Virol. 70, 8653-8659.
15. Garrone, P., Neidhardt, E.-M., Garcia, E., Galibert, L., van Kooten, C., and Banchereau, J. (1995). Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 182, 1265-1273.
16. Goodnow, C.C. (1996). Balancing immunity and tolerance: deleting and tuning lymphocytes repertoires. Proc. Natl. Acad. Sci. USA 93, 2264-2271.
17. Gregory, C.D., Dive, C., Henderson, S., Smith, C.A., Williams, G.T., Gordon, J., and Rickinson, A.B. (1991). Activation of Epstein-Barr virus latent genes protects human B cell from death by apoptosis. Nature 349, 612-614.
18. Grillot, D.A., Merino, R., Pena, J.C., Fanslow, W.C., Finkelman, F.D., Thompson, C.B., and Nunez, G. (1996). Bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J. Exp. Med. 183, 381-391.
19. INK4B/MTS2-related CDK inhibitor, correlates with Wild-type pRb function. Gene Dev. 8, 2939-2952.
20. Hammerschmidt, W., and Sugden, B. (1989). Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340, 393-397.
21. Hammerskjold, M.L., and Simurda, M.C. (1992). Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-κB activity. J. Virol. 66, 6496-6501.
22. Henderson, S., Rowe, M., Gregory, C., Croom-Carter, D., Wang, F., Longnecker, R., Kieff, E., and Rickinson, A. (1991). Induction of Bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65, 1107-1115.
23. Ho, F., Lortan, J.E., MacLennan, I.C.M., and Khan, M. (1986). Distinct short-lived and long-lived antibody-producing cell populations. Eur. J. Immunol. 16, 1297-1301.
24. Hsu, W., Kerppola, T.K., Chen, P.-L., Curran, T., and Chen-Kiang, S. (1994). Fos and Jun repress transcription activation by NF-IL6 through association at the basic zipper region. Mol. Cell. Biol. 14, 268-276.
25. Jin, X.W., and Speck, S.H. (1992). Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter. J. Virol. 66, 2746-2852.
26. Jochner, N., Eick, D., Zimber-Strobl, U., Pawlita, M., Bornkamm, G.W., and Kempkes, B. (1996). Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin μ gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells EMBO J. 15, 375-382.
27. Kaye, K.M., Izumi, K.M., and Kieff, E. (1993). Epstein-Barr virus latent membrane protein 1 is essential for B lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 90, 9150-9154.
28. Kelleher, C.A., Kaufman Peterson, R., Dreyfus, D.H., Streib, J.E., Wu Xu, J., Takase, K., Jones, J.F., and Gelfand, E.W. (1995). Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ. Virology 208, 685-695.
29. Kempkes, B., Spitkovsky, D., Janssen-Dürr, P., Ellwart, J.W., Kremmer, E., Delecluse, H.J., Rottenberger, C., Bornkamm, G.W., and Hammerschmidt, W. (1995). B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2. EMBO J. 14, 88-96.
30. Kieff, E. (1996). Epstein-Barr virus and its replication. In Virology, B.N. Fields, D.M. Knipe, and P. M. Howley, eds. (New York; Lippincott-Raven), pp. 2343-2396.
31. Koopman, G., Reutelingsperger, C.P.M., Kuijten, G.A.M., Keehnen, R.M.J., Pals, S.T., and van Oers, M.H. J. (1994). Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84, 1415-1420.
32. Kozopas, K.M., Yang, T., Buchan, H.L., Zhou, P., and Craig, R.W. (1993). MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL-2. Proc. Natl. Acad. Sci. USA 90, 3516-3520.
33. Krajewski, S., Krajewska, M., Shabaik, A., Wang, H.-G., Irie, S., Fong, L., and Reed, J.C. (1994). Immunohistochemical analysis of in vivo patterns of Bcl-x expression. Cancer Res. 54, 5501-5507.
34. Krajewski, S., Bodrug, S., Krajewska, M., Shabaik, A., Gascoyne, R., Berean, K., and Reed, J.C. (1995). Immunohistochemical analysis of Mcl-1 protein in human tissues: differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am. J. Pathol. 146, 1309-1319.
35. Krammer, P.H., Dhein, J., Walczak, H., Behrmann, I., Mariani, S., Matiba, B., Fath, M., Daniel, P.T., Knipping, E., Westendorp, M.O., et al. (1994). The role of APO-1-mediated apoptosis in the immune system. Immunol. Rev. 142, 175-191.
36. Laherty, C.D., Hu, H.M., Opipari, A.W., Wang, F., and Dixit, V.M. (1992). The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kB. J. Biol. Chem 267, 24157-24160.
37. Lazebnik, Y.A., Kaufmann, S.H., Desnoyers, S., Poirier, G.G., and Earnshaw, W.C. (1994). Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346-347.
38. Lomo, J., Smeland, E.B., Krajewski, S., Reed, J.C., and Blomhoff, H.K. (1996). Expression of the Bcl-2 homologue Mcl-1 correlates with survival of peripheral blood B lymphocytes. Cancer Res. 56, 40-43.
39. Martin, J.M., Veis, D., Korsmeyer, S.J., and Sugden, B. (1993). Latent membrane protein of Epstein-Barrvirus induces cellular phenotypes independently of expression of Bcl-2. J. Virol. 67, 5269-5278.
40. Martin, S.J., Reutelingsperger, C.P.M., McGahon, A.J., Rader, J.A., van Schie, R.C.A.A., LaFace, D.M., and Green, D.R. (1995). Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182, 1545-1556.
41. May, L., Shaw, J.E., Khanna, A.K., Zabriskie, J.B., and Sehgal, P.B. (1991). Marked cell-type-specific differences in glycosylation of human interleukin-6. Cytokine 3, 204-211.
42. McDonnell, T.J., Deane, N., Platt, P.M., Nunez, G., Jaeger, U., McKearn, J.P., and Korsmeyer, S.J. (1989). Bcl-2-immunoglobulin transgenic mice demonstrate extented B cell survival and follicular lymphoproliferation. Cell 57, 79-88.
43. Merville, P., Déchanet, J., Desmoulière, A., Durand, I., de Bouteiller, O., Garrone, P., Banchereau, J., and Liu, Y.-J. (1996). Bcl-2+ tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts. J. Exp. Med. 183, 227-236.
44. Morse, L., Chen, D., Franklin, D., Xiong, Y., and Chen-Kiang, S. (1997). Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18INK4c and IL-6. Immunity 6, 47-56.
45. Mosialos, G., Birkenbach, M., Yalamanchili, R., VanArsdale, T., Ware, C., and Kieff, E. (1995). The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80, 389-399.
46. Nagata, S. (1997). Apoptosis by death factor. Cell 88, 355-365.
47. Natkunam, Y., Zhang, X., Liu, Z., and Chen-Kiang, S. (1994). Simultaneous activation of immunoglobulin and Oct-2 synthesis and repression of surface MHC class II expression by IL-6. J. Immunol. 153, 3476-3484.
48. Nicholson, D.W., Ali, A., Thornberry, N.A., Vaillancourt, J.P., Ding, C.K., Gallant, M., Gareau, Y., Griffin, P.R., Labelle, M., Lazebnik, Y.A., et al. (1995). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37-43.
49. Pearson, G.R., Vroman, B., Chase, B., Sculley, T., Hummel, M., and Kieff, E. (1983). Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies. J. Virol. 47, 193-201.
50. Quelle, D.E., Ashmun, R.A., Shurtleff, S.A., Kato, J.-Y., Bar-Sagi, D., Roussel, M.F., and Sherr, C.J. (1993). Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblats. Genes Dev. 7, 1559-1571.
51. Rathmell, J.C., Townsend, S.E., Xu, J.C., Flavell, R.A., and Goodnow, C.C. (1996). Expansion or elimination of B cells in vivo: dual roles for CD40 and Fas (CD95) ligands modulated by the B cell antigen receptor. Cell 87, 319-329.
52. Raynal, M.-C., Liu, Z., Hirano, T., Mayer, L., Kishimoto, T., and Chen-Kiang, S. (1989). Interleukin-6 induces secretion of IgG1 by coordinated transcriptional activation and differential mRNA accumulation. Proc. Natl. Acad. Sci. USA 86, 8024-8028.
53. Reed, J.C. (1994). Bcl-2 and the regulation of programmed cell death. J. Cell. Biol., 124, 1-6.
54. Rochford, R., and Mosier, D.E. (1995). Differential Epstein-Barrvirus gene expression in B-cell subsets recovered from lymphomas in SCID mice after transplantation of human peripheral blood lymphocytes. J. Virol. 69, 150-155.
55. Rochford, R., Hobbs, M.V., Garnier, J.-L., Cooper, N.R., and Cannon, M.J. (1993). Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes. Proc. Natl. Acad. Sci. USA 90, 352-356.
56. Roeckel, D., Boos, H., and Mueller-Lantsach, N. (1987). Expression of an early Epstein-Barr virus antigen (EA-D) in E. coli. Arch. Virol. 97, 366-372.
57. Rooney, C., Howe, J.G., Speck, S.H., and Miller, G. (1989). Influences of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 stain of Epstein-Barr virus. J. Virol. 63, 1531-1539.
58. Rooney, C., Brimmell, M., Buschle, M., Allan, G., Farrell, P.J., and Kolman, J.L. (1992). Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes. J. Virol. 66, 496-504.
59. Rothstein, T.L., Wang, J.K.M., Panka, D.J., Foote, L.C., Wang, Z., Stanger, B., Cui, H., Ju, S.-T., and Marshak-Rothstein, A. (1995). Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374, 163-165.
60. Sarma, V., Lin, Z., Clark, L., Rust, B.M., Tewari, M., Noelle, R.J., and Dixit, V.M. (1995). Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Biol. Chem. 270, 12343-12346.
61. Schaffner, E.J., Elkon, K.B., Yoo, D.-H., Tumang, J., Krammer, P.H., Crow, M.K., and Friedman, S.M. (1995). CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 182, 1557-1565.
62. Sinclair, A.J., Palmero, I., Peters, G., and Farrell, P.J. (1994). EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J. 13, 3321-3328.
63. Sung, N.S., Kenney, S., Gutsch, D., and Pagano, J.S. (1991). EBNA-2 transactivates a lymphoid-specific enhancer in the BamH1 C promoter of Epstein-Barr virus. J. Virol. 65, 2164-2169.
64. Takayama, S., Sato, T., Krajewski, S., Kochel, K., Irie, S., Millan, J.A. and Reed, J.C. (1995). Cloning and functional analysis of Bag-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 80, 279-284.
65. Tomkinson, B., Robertson, E., and Kieff, E. (1993). Epstein-Barr virus nuclear proteins (EBNA) 3A and 3C are essential for B lymphocyte growth transformation. J. Virol. 67, 2014-2025.
66. Wang, F., Tsang, S., Kurilla, M., Cohen, J., and Kieff, E. (1990). Epstein-Barr virus nuclear antigen 2 transactivates the latent membrane protein (LMP1). J. Virol. 64, 3407-3416.
67. Woisetschlaeger, M., Jin, X.W., Yandava, C.N., Furmanski, L.A., Strominger, J.L., and Speck, S.H. (1991). Role of the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection. Proc. Natl. Acad. Sci. USA 88, 3942-3946.
68. L, and Bcl-2, displaces Bax and promotes cell death. Cell 80, 285-291.
69. Yang, T., Kozopas, K.M., and Craig, R.W. (1995). The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2. J. Cell Biol. 128, 1173-1184.
70. Zhou, P., Qian, L., Kozopas, K.M., and Craig, R.W. (1997). Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood 89, 630-643.
71. Zimber-Strobl, U., Suentzenich, K.O., Laux, G., Eick, D., Cordier, M., Calender, A., Billaud, M., Lenoir, G.M., and Bornkamm, G.W. (1991). Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene. J. Virol. 65, 415-423.
72. Zimber-Strobl, U., Kremmer, E., Graesser, F., Marschall, G., Laux, G. and Bornkasmm, G.W. (1993). The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter. EMBO J. 12, 167-175.
73. Zimber-Strobl, U., Kempkes, B., Marschall, G., Zeidler, R., van Kooten, G., Banchereau, J., Bornkamm, G.W., and Hammerschmidt, W. (1996). Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival. EMBO J. 15, 7070-7078.